Strides Pharma Science Ltd (SRID)

Currency in INR
987.10
+19.30(+1.99%)
Closed·

SRID Earnings

Latest Release
Jul 31, 2026
EPS / Forecast
17.00 / --
Revenue / Forecast
12.65B / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/----/12.20B----Free Sign Up
2026/0617.00/--12.65B/------Free Sign Up
2026/0313.80/--13.24B/------Free Sign Up
2025/1221.90/--11.95B/11.23B--+6.44%Free Sign Up
2025/0914.40/--12.21B/------Free Sign Up
2025/0610.80/--11.20B/------Free Sign Up
2025/038.90/--11.90B/------Free Sign Up
2024/129.55/--11.54B/10.38B--+11.19%Free Sign Up
2024/094.80/--12.01B/11.12B--+8%Free Sign Up
2024/067.60/8.4510.88B/10.88B-10.06%0%Free Sign Up

All numbers in INR

Strides Pharma Science Ltd Earnings Call Summary for Q1/2027

  • Strides Pharma Q1 revenue rose 13% YoY to INR 1,265 crores; shares fell 4.46% on margin concerns and soft U.S. outlook despite 57% reported PAT jump.
  • EBITDA margin declined 130 bps to 18.2% amid higher freight costs; gross margin improved 60 bps to 60.9% showing operational resilience.
  • Management expects soft H1 with stronger H2 driven by 10 product launches; maintains $375M North America revenue target by fiscal 2028.
  • Ex-U.S. business outperformed with 17% growth; company holds top-3 positions in 37 U.S. products representing 70% of U.S. revenue.
  • Net debt decreased to INR 1,425 crores; company targets debt neutrality in 2-3 years while focusing on controlled substances and specialty products.
Last Updated: 2026-07-31, 08:50 a/m
Read Full Transcript

FAQ

What Is Strides Pharma's Earnings Per Share (TTM)?

The Strides Pharma EPS (TTM) is 66.55.

When Is The Next Strides Pharma Earnings Date?

Strides Pharma will release its next earnings report on Oct 29, 2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.